New York policy
A6927: Relates to prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy
NY Assembly · Sponsor Tony Simone
- Jurisdiction
- New York State
- Applies to
- New York State (proposed)
- Effective
- May 28, 2026
What it requires
Provides that prescription labels for gonadotropin-releasing hormone agonists, pubertal suppressants, anabolic steroids, alpha reductase inhibitors, progestins, or drug classes for hormone replacement therapy maybe include the name of the dispensing practice instead of the prescriber; provides for notice to patients.
ny-stateassemblylegislationbill
Free account
Create a free account
Track New York policy and save searches across the Network. Free. No card required.
Want to turn policy like this into market and network moves? Build your Market Network Strategic Plan →
